Raj Chakraborty @rajshekharucms

Hematologist/Oncologist/Clinical Researcher @ColumbiaCancer #Myeloma #Amyloidosis Asst. Prof @ColumbiaMed Host @BloodCancerTalk COI: https://t.co/du0rVMRFkC New York, NY Joined May 2010

Tweets

6K
Followers

5K
Following

337
Likes

10K

Eddie Cliff @Eddie_Cliff

2 days ago

Don't miss our @icmlugano & @EHA_Hematology lymphoma round-up episode @BloodCancerTalk: Bispecific Bonanza with @AdrianMinson @PeterMacCC SUNMO POLARGO STARGLO R-Pola-Glo LOTIS-7 ...and more Wherever you get your podcasts #lymsm @mike_dickinson1 @rajshekharucms

0 6 34 4K 7

Download Video

Outcomes of 1477 TIE patients tx in Canada (n=742 Rd, n=392 VRd, n=343 DRd). DRd outperforms for both TTNT and OS. Hopefully quads getting funded soon. thank you team with @rajshekharucms, nadine A, @End_myeloma, Alissa V, @Rfonsi1, @myelomaMD @McMasterU @HamiltonMyeloma

0 4 26 3K 4

Download Image

Adam Cifu @adamcifu

a week ago

Some things we don’t need to investigate. open.substack.com/pub/sensibleme…

12 27 115 29K 30

Mansi Shah @MansiShahMD

a week ago

Our multicenter series shows bispecific antibodies may offer meaningful CNS activity with manageable safety. Led by fellow Alex N! @MeeraMohanMD @HadidiSamer doi.org/10.1111/bjh.70… #CNSMyeloma #mmsm @RutgersCancer @RWJBarnabas

3 14 48 5K 10

Saurabh Zanwar @ZanwarSaurabh

2 weeks ago

@WilliamAird4 Unfortunately common, especially IgM. Transient reactions most likely. @sykristinsson et al (iSTOPMM) have shown that prospectively as a relatively frequent catch. ashpublications.org/blood/article/…

0 2 23 1K 7

Garry Tan @garrytan

2 weeks ago

If you *only* used SAT to admit to elite colleges, share of admits from top 1% income falls 15.8% → 9.9% and representation from <$200k rises by +8.8%, with no reduction in post-college outcomes. It's 'holistic review' and 'ban SAT' policy that allows the most wealthy and…

306 2K 13K 1.6M 3K

Download Image

Anil Makam @AnilMakam

2 weeks ago

Free epidemiology lesson that will make you a better doctor when you see survival curves diverge way sooner than biological plausibility or what prior trials have shown, it is a dead giveaway something is amiss usually its selection bias I love GLP1ra but they're not magic

8 18 126 14K 56

Download Image

Paolo Tarantino @PTarantinoMD

2 weeks ago

Great read by @SuyogCancer, highlighting the challenges faced by letters to the editor, which have progressively lost appeal & impact. Their lost space has been filled by social media, which - despite far from perfect - enable speed, interaction & spread. oncologynewscentral.com/oncology/what-…

3 15 52 15K 5

Download Image

Raj Chakraborty @rajshekharucms

2 weeks ago

Important clinical pearl from @Ron_Witteles! In cardiac AL, I check FLCs q-weekly in the first couple of months, and switch treatment if I sense plateau. “Every day matters” for the component of toxic cardiomyopathy from circulating FLCs.

Ronald Witteles @Ron_Witteles

2 weeks ago

4 8 44 8K 6

2 4 16 3K 3

Blood Cancer Talks @BloodCancerTalk

2 weeks ago

Tune in to our new episode on EHA and ICML 2025 updates in #lymphoma with @AdrianMinson @PeterMacCC! share.transistor.fm/s/d8c0f8ec Here is a clip of Dr. Minson's take on the Epcor + R-ICE data

1 7 19 2K 7

Download Video

Raj Chakraborty @rajshekharucms

3 weeks ago

Having encountered a series of patients with hyperviscosity syndrome lately, came across this gem of a paper by @MorieGertz in @BloodPortfolio on acute hyperviscosity syndromes across plasma cell disorders (and more). It explains not only the clinical presentation/management but…

4 6 37 2K 9

Download Image

Raj Chakraborty @rajshekharucms

3 weeks ago

Insightful article in @JAMAOnc on the oncology social media discourse. While I disagree on "guidelines" or policing of social media content by organizations, the finding that research posts are 7x more likely to be supportive than critical in concerning, and highlights the need…

JAMA Oncology @JAMAOnc

a month ago

3 12 53 43K 20

Download Image

2 3 13 2K 0

Murali Janakiram @JanakiramMurali

4 weeks ago

We want to share this important toxicity profile of GPRC5D BisAb- Talquetamab. GPRC5D Bispecific antibody talquetamab-induced dizziness-ataxia syndrome, clinical presentation and management- a case series nature.com/articles/s4140… Full link- rdcu.be/eAazx

7 31 67 9K 25

Download Image

Al Garfall @AlGarfall

4 weeks ago

@rajshekharucms @BloodCancerTalk Of course there are many varieties of clinical research careers that all make valuable contributions and may be less time intensive. But you do need enough volume to your practice to generate good ideas and enough patients to complete studies. But protocols/grants etc take time.

1 1 5 404 0

Raj Chakraborty @rajshekharucms

4 weeks ago

Given the spirited discussions generated by this tweet, sharing this insightful clip featuring the legendary Dr. Tefferi @BloodCancerTalk, where his key message for aspiring clinical investigators was to maintain a busy clinical practice in order to become an effective clinical…

Dr. Glaucomflecken @DGlaucomflecken

4 weeks ago

183 576 6K 643K 338

1 7 37 5K 9

Download Video

David Russler-Germain, MD/PhD @dgermain21

4 weeks ago

He has a very valid point. I agree there’s too much low rigor research being done purely for CV padding, and trainees should see more patients or pursue more formalized, longitudinal research mentoring.

Dr. Glaucomflecken @DGlaucomflecken

4 weeks ago

149 284 4K 322K 192

2 1 14 2K 0

chadi nabhan MD, MBA, FACP @chadinabhan

a month ago

Misinformation and the AMA Controversy With Ed Livingston youtu.be/TOM2kdXXXKU?si… via @YouTube The #HealthcareUnfiltered episode W @ehlJAMA is on my YouTube - watch, subscribe, like, comment, and share your feedback in the comments and/or here.

4 9 20 20K 12

Kristin M. Collier, MD @HSRdirector

a month ago

new piece by my @umichmedicine @UMIntMed colleague @sanjaysaint and others. Religious attendance provides a dose-dependent protective effect against stress-induced depression throughout medical internship across many ethnic groups.

0 6 31 2K 4

Download Image

Bishal Gyawali, MD, PhD, FASCO @oncology_bg

a month ago

Cancer incidence is increasing in younger population. Yes, that should concern us. But that doesn’t automatically mean “therefore, we should start screening from earlier age”. In fact, if incidence has increased without mortality increasing, the increased incidence could simply…

2 5 29 2K 3

Nico Gagelmann @NicoGagelmann

a month ago

Submission of an abstract costs non-refundable 85$. And may take sometimes up to 1 hour. This feels and is wrong. There must be another way that is efficient and FAIR for everyone.